First Light Asset Management, LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1600004
EDINA, MN
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,923,605
+$11,346,791 QoQ
Shares Held
1,360,866
+24.9% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
3.10%
of 13F equity value
Holder Rank
#21
of 266 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026First Light Asset Management, LLC holds $573,690,960 across 11 Biotechnology names. CRNX ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
930,289 | $123,477,258 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
771,901 | $117,961,910 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
|
1,360,750 | $69,058,062 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
This page
|
1,360,866 | $50,923,605 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,095,171 | $44,496,797 | |
| 6 | ANAB |
Anaptysbio, Inc
|
582,004 | $39,285,270 | |
| 7 | TRVI |
Trevi Therapeutics, Inc.
|
2,097,215 | $39,113,059 | |
| 8 | SEPN |
Septerna, Inc.
|
963,260 | $32,259,577 |
All Filings in CRNX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,923,605 | 1,360,866 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,576,814 | 1,089,670 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $55,592,942 | 1,194,263 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $39,214,141 | 941,516 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,852,551 | 864,136 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,690,753 | 855,419 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $45,273,211 | 885,453 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $48,218,522 | 943,611 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $53,770,753 | 1,200,508 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $79,117,185 | 1,690,177 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $70,724,927 | 1,987,772 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $47,088,204 | 1,583,329 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,061,140 | 1,557,222 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $26,003,147 | 1,619,125 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,326,427 | 1,329,313 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,448,245 | 1,346,652 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,137,357 | 1,240,609 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,791,735 | 582,767 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,750,134 | 272,796 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||